BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36209796)

  • 21. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
    Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
    Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos).
    Fusaroli P; Serrani M; De Giorgio R; D'Ercole MC; Ceroni L; Lisotti A; Caletti G
    Pancreas; 2016 Feb; 45(2):265-8. PubMed ID: 26474428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA testing of pancreatic cyst fluid: is it ready for prime time?
    Singhi AD; Nikiforova MN; McGrath K
    Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):63-72. PubMed ID: 28404017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Ancillary Testing on Endoscopic US-Guided Fine Needle Aspiration Samples from Cystic Pancreatic Neoplasms.
    Jhala N; Srimunta P; Jhala D
    Acta Cytol; 2020; 64(1-2):124-135. PubMed ID: 31509835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts.
    Basar O; Yuksel O; Yang DJ; Samarasena J; Forcione D; DiMaio CJ; Wagh MS; Chang K; Casey B; Fernandez-Del Castillo C; Pitman MB; Brugge WR
    Gastrointest Endosc; 2018 Jul; 88(1):79-86. PubMed ID: 29510146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
    Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
    Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
    Panarelli NC; Sela R; Schreiner AM; Crapanzano JP; Klimstra DS; Schnoll-Sussman F; Pochapin MB; Yantiss RK
    Am J Surg Pathol; 2012 Oct; 36(10):1434-43. PubMed ID: 22982886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
    Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
    J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of serous cystic neoplasms of the pancreas.
    Antonini F; Fuccio L; Fabbri C; Macarri G; Palazzo L
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):115-25. PubMed ID: 24981593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted next-generation sequencing of EUS-guided through-the-needle-biopsy sampling from pancreatic cystic lesions.
    Rift CV; Melchior LC; Kovacevic B; Klausen P; Toxværd A; Grossjohann H; Karstensen JG; Brink L; Hassan H; Kalaitzakis E; Storkholm J; Scheie D; Hansen CP; Lund EL; Vilmann P; Hasselby JP
    Gastrointest Endosc; 2023 Jan; 97(1):50-58.e4. PubMed ID: 35964683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.
    Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J
    Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing
    Faias S; Pereira L; Luís Â; Chaves P; Cravo M
    World J Gastroenterol; 2019 Jul; 25(26):3450-3467. PubMed ID: 31341368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Society Guidelines for the Management and Surveillance of Pancreatic Cysts: A Review.
    Aziz H; Acher AW; Krishna SG; Cloyd JM; Pawlik TM
    JAMA Surg; 2022 Aug; 157(8):723-730. PubMed ID: 35731507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential molecular and cytologic analyses provides a complementary approach to the diagnosis of pancreatic cystic lesions: a decade of clinical practice.
    Sakhdari A; Moghaddam PA; Pejchal M; Cosar EF; Hutchinson L
    J Am Soc Cytopathol; 2020; 9(1):38-44. PubMed ID: 31711852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis with pancreaseq® in evaluation and management of pancreatic cysts: A cohort of 28 patients.
    Ardor GD; Hanna H; Ozalp B; Nassar A
    Cytojournal; 2023; 20():23. PubMed ID: 37681071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of molecular markers and clinical features improve the classification of pancreatic cysts.
    Springer S; Wang Y; Dal Molin M; Masica DL; Jiao Y; Kinde I; Blackford A; Raman SP; Wolfgang CL; Tomita T; Niknafs N; Douville C; Ptak J; Dobbyn L; Allen PJ; Klimstra DS; Schattner MA; Schmidt CM; Yip-Schneider M; Cummings OW; Brand RE; Zeh HJ; Singhi AD; Scarpa A; Salvia R; Malleo G; Zamboni G; Falconi M; Jang JY; Kim SW; Kwon W; Hong SM; Song KB; Kim SC; Swan N; Murphy J; Geoghegan J; Brugge W; Fernandez-Del Castillo C; Mino-Kenudson M; Schulick R; Edil BH; Adsay V; Paulino J; van Hooft J; Yachida S; Nara S; Hiraoka N; Yamao K; Hijioka S; van der Merwe S; Goggins M; Canto MI; Ahuja N; Hirose K; Makary M; Weiss MJ; Cameron J; Pittman M; Eshleman JR; Diaz LA; Papadopoulos N; Kinzler KW; Karchin R; Hruban RH; Vogelstein B; Lennon AM
    Gastroenterology; 2015 Nov; 149(6):1501-10. PubMed ID: 26253305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.